Ptc Therapeutics (PTCT) Return on Sales (2016 - 2025)
Historic Return on Sales for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to 0.08%.
- Ptc Therapeutics' Return on Sales rose 6200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 10300.0%. This contributed to the annual value of 0.78% for FY2024, which is 100.0% down from last year.
- Per Ptc Therapeutics' latest filing, its Return on Sales stood at 0.08% for Q3 2025, which was up 6200.0% from 0.36% recorded in Q2 2025.
- Ptc Therapeutics' 5-year Return on Sales high stood at 0.74% for Q1 2025, and its period low was 1.54% during Q4 2024.
- In the last 5 years, Ptc Therapeutics' Return on Sales had a median value of 0.8% in 2023 and averaged 0.69%.
- Its Return on Sales has fluctuated over the past 5 years, first surged by 14000bps in 2021, then tumbled by -7400bps in 2024.
- Ptc Therapeutics' Return on Sales (Quarter) stood at 0.87% in 2021, then decreased by -20bps to 1.04% in 2022, then increased by 24bps to 0.8% in 2023, then crashed by -93bps to 1.54% in 2024, then soared by 105bps to 0.08% in 2025.
- Its Return on Sales was 0.08% in Q3 2025, compared to 0.36% in Q2 2025 and 0.74% in Q1 2025.